BioSig Technologies Inc BSGM.OQ BSGM.O is expected to show a fall in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2025
LSEG's mean analyst estimate for BioSig Technologies Inc is for a loss of 4 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for BioSig Technologies Inc is $10.00, about 63.2% above its last closing price of $3.68
This summary was machine generated August 8 at 21:26 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)